These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 11316849

  • 1. Specific antagonism of PDGF prevents renal scarring in experimental glomerulonephritis.
    Ostendorf T, Kunter U, Gröne HJ, Bahlmann F, Kawachi H, Shimizu F, Koch KM, Janjic N, Floege J.
    J Am Soc Nephrol; 2001 May; 12(5):909-918. PubMed ID: 11316849
    [Abstract] [Full Text] [Related]

  • 2. Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis.
    Ostendorf T, Rong S, Boor P, Wiedemann S, Kunter U, Haubold U, van Roeyen CR, Eitner F, Kawachi H, Starling G, Alvarez E, Smithson G, Floege J.
    J Am Soc Nephrol; 2006 Apr; 17(4):1054-62. PubMed ID: 16510766
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The effects of platelet-derived growth factor antagonism in experimental glomerulonephritis are independent of the transforming growth factor-beta system.
    Ostendorf T, Kunter U, van Roeyen C, Dooley S, Janjic N, Ruckman J, Eitner F, Floege J.
    J Am Soc Nephrol; 2002 Mar; 13(3):658-667. PubMed ID: 11856769
    [Abstract] [Full Text] [Related]

  • 5. Mesangial cell expression of proto-oncogene Ets-1 during progression of mesangioproliferative glomerulonephritis.
    Raffetseder U, Wernert N, Ostendorf T, van Roeyen C, Rauen T, Behrens P, Floege J, Mertens PR.
    Kidney Int; 2004 Aug; 66(2):622-32. PubMed ID: 15253715
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers.
    Floege J, Ostendorf T, Janssen U, Burg M, Radeke HH, Vargeese C, Gill SC, Green LS, Janjić N.
    Am J Pathol; 1999 Jan; 154(1):169-79. PubMed ID: 9916931
    [Abstract] [Full Text] [Related]

  • 9. A novel, dual role of CCN3 in experimental glomerulonephritis: pro-angiogenic and antimesangioproliferative effects.
    van Roeyen CR, Boor P, Borkham-Kamphorst E, Rong S, Kunter U, Martin IV, Kaitovic A, Fleckenstein S, Perbal B, Trautwein C, Weiskirchen R, Ostendorf T, Floege J.
    Am J Pathol; 2012 May; 180(5):1979-90. PubMed ID: 22538190
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. C-type natriuretic peptide inhibits mesangial cell proliferation and matrix accumulation in vivo.
    Canaan-Kühl S, Ostendorf T, Zander K, Koch KM, Floege J.
    Kidney Int; 1998 May; 53(5):1143-51. PubMed ID: 9573528
    [Abstract] [Full Text] [Related]

  • 14. Low-dose mTOR inhibition by rapamycin attenuates progression in anti-thy1-induced chronic glomerulosclerosis of the rat.
    Krämer S, Wang-Rosenke Y, Scholl V, Binder E, Loof T, Khadzhynov D, Kawachi H, Shimizu F, Diekmann F, Budde K, Neumayer HH, Peters H.
    Am J Physiol Renal Physiol; 2008 Feb; 294(2):F440-9. PubMed ID: 18094032
    [Abstract] [Full Text] [Related]

  • 15. Nicorandil improves glomerular injury in rats with mesangioproliferative glomerulonephritis via inhibition of proproliferative and profibrotic growth factors.
    Sudo H, Hirata M, Kanada H, Yorozu K, Tashiro Y, Serizawa K, Yogo K, Kataoka M, Moriguchi Y, Ishizuka N.
    J Pharmacol Sci; 2009 Sep; 111(1):53-9. PubMed ID: 19721333
    [Abstract] [Full Text] [Related]

  • 16. Growth factor expression in a murine model of cryoglobulinemia.
    Taneda S, Hudkins KL, Cui Y, Farr AG, Alpers CE, Segerer S.
    Kidney Int; 2003 Feb; 63(2):576-90. PubMed ID: 12631122
    [Abstract] [Full Text] [Related]

  • 17. A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis.
    Ostendorf T, van Roeyen CR, Peterson JD, Kunter U, Eitner F, Hamad AJ, Chan G, Jia XC, Macaluso J, Gazit-Bornstein G, Keyt BA, Lichenstein HS, LaRochelle WJ, Floege J.
    J Am Soc Nephrol; 2003 Sep; 14(9):2237-47. PubMed ID: 12937299
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Benidipine, a long-acting calcium-channel blocker, prevents the progression to end-stage renal failure in a rat mesangioproliferative glomerulonephritis.
    Nakamura T, Obata JE, Onitsuka M, Shimada Y, Yoshida Y, Kawachi H, Shimizu F.
    Nephron; 2000 Nov; 86(3):315-26. PubMed ID: 11096289
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.